Dieckol, a Major Marine Polyphenol, Enhances Non-Rapid Eye Movement Sleep in Mice via the GABAA-Benzodiazepine Receptor

We had previously demonstrated that phlorotannins, which are marine polyphenols, enhance sleep in mice via the GABA A -benzodiazepine (BZD) receptor. Among the constituents of phlorotannin, dieckol is a major marine polyphenol from the brown alga Ecklonia cava . Although phlorotannins are known to e...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in pharmacology 2020-04, Vol.11, p.494-494
Main Authors: Yoon, Minseok, Kim, Jin-Soo, Seo, Sangwoo, Lee, Kiwon, Um, Min Young, Lee, Jaekwang, Jung, Jonghoon, Cho, Suengmok
Format: Article
Language:English
Subjects:
dieckol
electroencephalogram
hypnotic
marine polyphenols
Pharmacology
phlorotannins
sleep
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We had previously demonstrated that phlorotannins, which are marine polyphenols, enhance sleep in mice via the GABA A -benzodiazepine (BZD) receptor. Among the constituents of phlorotannin, dieckol is a major marine polyphenol from the brown alga Ecklonia cava . Although phlorotannins are known to exert hypnotic effects, the sleep-enhancing effect of dieckol has not yet been determined. We evaluated the effect of dieckol on sleep-wake state of mice by analyzing electroencephalograms (EEGs) and electromyograms. Flumazenil, a GABA A -BZD antagonist, was used to investigate the molecular mechanism underlying the effects of dieckol on sleep. The polygraphic recordings and corresponding hypnograms revealed that dieckol accelerated the initiation of non-rapid eye movement sleep (NREMS); it shortened sleep latency and increased NREMS duration. According to the change in time-course, dieckol showed sleep-enhancing effects by increasing the amount of NREMS and decreasing wakefulness during the same hours. Additionally, sleep quality was evaluated by analyzing the EEG power density, and dieckol was found to not affect sleep intensity while zolpidem was found to reduce it. Finally, we treated mice with zolpidem or dieckol in combination with flumazenil and found the latter to inhibit the sleep-enhancing effect of dieckol and zolpidem, thereby indicating that dieckol exerts sleep-enhancing effects by activating the GABA A -BZD receptor, similar to zolpidem. These results implied that dieckol can be used as a promising herbal sleep aid with minimal side effects, unlike the existing hypnotics.
ISSN:1663-9812
1663-9812
DOI:10.3389/fphar.2020.00494